<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cicardi ME</submitter><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of General Medical Sciences</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke</funding><funding>NIA NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute on Aging</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>376</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10978903</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(1)</volume><pubmed_abstract>Expanded intronic G&lt;sub>4&lt;/sub>C&lt;sub>2&lt;/sub> repeats in the C9ORF72 gene cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). These intronic repeats are translated through a non-AUG-dependent mechanism into five different dipeptide repeat proteins (DPRs), including poly-glycine-arginine (GR), which is aggregation-prone and neurotoxic. Here, we report that Kapβ2 and GR interact, co-aggregating, in cultured neurons in-vitro and CNS tissue in-vivo. Importantly, this interaction significantly decreased the risk of death of cultured GR-expressing neurons. Downregulation of Kapβ2 is detrimental to their survival, whereas increased Kapβ2 levels mitigated GR-mediated neurotoxicity. As expected, GR-expressing neurons displayed TDP-43 nuclear loss. Raising Kapβ2 levels did not restore TDP-43 into the nucleus, nor did alter the dynamic properties of GR aggregates. Overall, our findings support the design of therapeutic strategies aimed at up-regulating Kapβ2 expression levels as a potential new avenue for contrasting neurodegeneration in C9orf72-ALS/FTD.</pubmed_abstract><journal>Communications biology</journal><pubmed_title>The nuclear import receptor Kapβ2 modifies neurotoxicity mediated by poly(GR) in C9orf72-linked ALS/FTD.</pubmed_title><pmcid>PMC10978903</pmcid><funding_grant_id>NS114128</funding_grant_id><funding_grant_id>AG057882</funding_grant_id><funding_grant_id>GM138109</funding_grant_id><funding_grant_id>R35 GM138109</funding_grant_id><funding_grant_id>R01 NS109150</funding_grant_id><funding_grant_id>R21 NS090912</funding_grant_id><funding_grant_id>RF1 AG057882</funding_grant_id><funding_grant_id>NS109150</funding_grant_id><funding_grant_id>NS090912</funding_grant_id><funding_grant_id>RF1 NS114128</funding_grant_id><pubmed_authors>Krishnamurthy K</pubmed_authors><pubmed_authors>Verdone BM</pubmed_authors><pubmed_authors>Markandaiah SS</pubmed_authors><pubmed_authors>Haeusler AR</pubmed_authors><pubmed_authors>Pasinelli P</pubmed_authors><pubmed_authors>Girdhar A</pubmed_authors><pubmed_authors>Boehringer A</pubmed_authors><pubmed_authors>Cicardi ME</pubmed_authors><pubmed_authors>Sriramoji S</pubmed_authors><pubmed_authors>Guo L</pubmed_authors><pubmed_authors>Rivas LB</pubmed_authors><pubmed_authors>Trotti D</pubmed_authors><pubmed_authors>Kankate V</pubmed_authors><pubmed_authors>Nelson A</pubmed_authors></additional><is_claimable>false</is_claimable><name>The nuclear import receptor Kapβ2 modifies neurotoxicity mediated by poly(GR) in C9orf72-linked ALS/FTD.</name><description>Expanded intronic G&lt;sub>4&lt;/sub>C&lt;sub>2&lt;/sub> repeats in the C9ORF72 gene cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). These intronic repeats are translated through a non-AUG-dependent mechanism into five different dipeptide repeat proteins (DPRs), including poly-glycine-arginine (GR), which is aggregation-prone and neurotoxic. Here, we report that Kapβ2 and GR interact, co-aggregating, in cultured neurons in-vitro and CNS tissue in-vivo. Importantly, this interaction significantly decreased the risk of death of cultured GR-expressing neurons. Downregulation of Kapβ2 is detrimental to their survival, whereas increased Kapβ2 levels mitigated GR-mediated neurotoxicity. As expected, GR-expressing neurons displayed TDP-43 nuclear loss. Raising Kapβ2 levels did not restore TDP-43 into the nucleus, nor did alter the dynamic properties of GR aggregates. Overall, our findings support the design of therapeutic strategies aimed at up-regulating Kapβ2 expression levels as a potential new avenue for contrasting neurodegeneration in C9orf72-ALS/FTD.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-05-29T11:22:04.889Z</modification><creation>2025-04-05T23:19:03.873Z</creation></dates><accession>S-EPMC10978903</accession><cross_references><pubmed>38548902</pubmed><doi>10.1038/s42003-024-06071-2</doi></cross_references></HashMap>